Transcatheter closure of post-infarction ventricular septal defect with the Amplatzer Septal Occluder device

Scand Cardiovasc J. 2000 Aug;34(4):446-8. doi: 10.1080/14017430050196315.

Abstract

There is an 80-90% mortality rate within the first 2 months of the occurrence of a post-infarction ventricular septal defect (VSD) with medical treatment alone. The muscular VSD presents a technical problem for the surgeon. Surgical treatment was unsuccessful in two patients. They were treated successfully using the Amplatzer Septal Occluder, with improvement in their condition.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angioplasty, Balloon, Coronary / methods
  • Aspirin
  • Cardiac Catheterization / instrumentation*
  • Cardiac Catheterization / methods
  • Follow-Up Studies
  • Heart Septal Defects, Ventricular / diagnosis
  • Heart Septal Defects, Ventricular / etiology*
  • Heart Septal Defects, Ventricular / therapy*
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Myocardial Infarction / complications*
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / therapy
  • Prosthesis Implantation / instrumentation
  • Prosthesis Implantation / methods*
  • Tissue Plasminogen Activator / administration & dosage
  • Treatment Outcome

Substances

  • Tissue Plasminogen Activator
  • Aspirin